• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

相似文献

1
Trends in Use and Expenditures of Brand-name Atorvastatin After Introduction of Generic Atorvastatin.品牌阿托伐他汀在仿制药阿托伐他汀推出后的使用和支出趋势。
JAMA Intern Med. 2018 May 1;178(5):719-721. doi: 10.1001/jamainternmed.2018.0990.
2
Effect of Generic Competition on Atorvastatin Prescribing and Patients' Out-of-Pocket Spending.通用竞争对阿托伐他汀处方和患者自付费用的影响。
JAMA Intern Med. 2016 Sep 1;176(9):1317-23. doi: 10.1001/jamainternmed.2016.3384.
3
Trends in Use and Expenditures for Brand-name Statins After Introduction of Generic Statins in the US, 2002-2018.2002-2018 年美国仿制药他汀类药物上市后品牌他汀类药物的使用和支出趋势。
JAMA Netw Open. 2021 Nov 1;4(11):e2135371. doi: 10.1001/jamanetworkopen.2021.35371.
4
[Comparison of compliance and cost effectiveness between brand-name statins and generic statins].[品牌他汀类药物与通用他汀类药物的依从性和成本效益比较]
Zhonghua Liu Xing Bing Xue Za Zhi. 2020 Nov 10;41(11):1900-1904. doi: 10.3760/cma.j.cn112338-20191114-00809.
5
Twenty-Year Nationwide Trends in Statin Utilization and Expenditure in Denmark.丹麦他汀类药物使用及支出的二十年全国趋势
Circ Cardiovasc Qual Outcomes. 2017 Jul;10(7). doi: 10.1161/CIRCOUTCOMES.117.003811.
6
Association of Industry Payments to Physicians With the Prescribing of Brand-name Statins in Massachusetts.医生收受制药企业回扣款与马萨诸塞州开具品牌名他汀类药物的关联性。
JAMA Intern Med. 2016 Jun 1;176(6):763-8. doi: 10.1001/jamainternmed.2016.1709.
7
Generic atorvastatin and health care costs.通用阿托伐他汀与医疗保健成本。
N Engl J Med. 2012 Jan 19;366(3):201-4. doi: 10.1056/NEJMp1113112. Epub 2011 Dec 7.
8
Zero copayment for generic statins could save billions.通用他汀类药物零自付费用可节省数十亿美元。
Manag Care. 2013 Mar;22(3):44.
9
Encouraging generic use can yield significant savings.鼓励使用仿制药可大幅节省成本。
Find Brief. 2012 Nov;15(8):1-3.
10
The impact of manufacturer coupon use in the statin market.制造商优惠券在他汀类药物市场中的影响。
J Manag Care Pharm. 2013 Nov-Dec;19(9):765-72. doi: 10.18553/jmcp.2013.19.9.765.

引用本文的文献

1
Statins utilization trends and expenditures in the U.S. before and after the implementation of the 2013 ACC/AHA guidelines.2013年美国心脏病学会/美国心脏协会（ACC/AHA）指南实施前后美国他汀类药物的使用趋势及支出情况。
Saudi Pharm J. 2023 Jun;31(6):795-800. doi: 10.1016/j.jsps.2023.04.002. Epub 2023 Apr 11.
2
The long-term effect of generic price competition on the Hungarian statin market.仿制药价格竞争对匈牙利他汀类药物市场的长期影响。
BMC Health Serv Res. 2023 May 6;23(1):447. doi: 10.1186/s12913-023-09431-6.
3
Health informatics interventions to minimize out-of-pocket medication costs for patients: what providers want.为患者尽量减少自付药费的健康信息学干预措施：医疗机构的需求
JAMIA Open. 2022 Feb 24;5(1):ooac007. doi: 10.1093/jamiaopen/ooac007. eCollection 2022 Apr.
4
Assessment of Hypothetical Out-of-Pocket Costs of Guideline-Recommended Medications for the Treatment of Older Adults With Multiple Chronic Conditions, 2009 and 2019.评估 2009 年和 2019 年治疗患有多种慢性病的老年人的指南推荐药物的假设自付费用。
JAMA Intern Med. 2022 Feb 1;182(2):185-195. doi: 10.1001/jamainternmed.2021.7457.
5
Trends in Use and Expenditures for Brand-name Statins After Introduction of Generic Statins in the US, 2002-2018.2002-2018 年美国仿制药他汀类药物上市后品牌他汀类药物的使用和支出趋势。
JAMA Netw Open. 2021 Nov 1;4(11):e2135371. doi: 10.1001/jamanetworkopen.2021.35371.
6
Can manipulation of gut microbiota really be transformed into an intervention strategy for cardiovascular disease management?肠道微生物群的操纵真的可以转化为心血管疾病管理的干预策略吗？
Folia Microbiol (Praha). 2021 Dec;66(6):897-916. doi: 10.1007/s12223-021-00926-5. Epub 2021 Oct 26.
7
Ophthalmic Medication Expenditures and Out-of-Pocket Spending: An Analysis of United States Prescriptions from 2007 through 2016.眼科药物支出和自付费用：对 2007 年至 2016 年美国处方的分析。
Ophthalmology. 2020 Oct;127(10):1292-1302. doi: 10.1016/j.ophtha.2020.04.037. Epub 2020 Apr 28.
8
Public knowledge, perception, and experience with generic medications in Saudi Arabia.沙特阿拉伯公众对仿制药的认知、看法和体验。
Saudi Med J. 2020 Apr;41(4):413-420. doi: 10.15537/smj.2020.4.24992.
9
Generic Drugs in the United States: Policies to Address Pricing and Competition.美国的仿制药：解决定价和竞争问题的政策。
Clin Pharmacol Ther. 2019 Feb;105(2):329-337. doi: 10.1002/cpt.1314. Epub 2019 Jan 10.

本文引用的文献

1
Medicare Spending and Potential Savings on Brand-Name Drugs With Available Generic Substitutes Excluded by 2 Large Pharmacy Benefit Managers, 2012 Through 2015.排除了 2 家大型药品福利管理公司的 2012 年至 2015 年有可用仿制药替代的品牌药物的医疗保险支出和潜在节省。
JAMA Intern Med. 2018 Apr 1;178(4):567-569. doi: 10.1001/jamainternmed.2017.8016.
2
National Trends in Statin Use and Expenditures in the US Adult Population From 2002 to 2013: Insights From the Medical Expenditure Panel Survey.2002 年至 2013 年美国成年人群体中他汀类药物的使用和支出的国家趋势：来自医疗支出调查的见解。
JAMA Cardiol. 2017 Jan 1;2(1):56-65. doi: 10.1001/jamacardio.2016.4700.
3
Effect of Generic Competition on Atorvastatin Prescribing and Patients' Out-of-Pocket Spending.通用竞争对阿托伐他汀处方和患者自付费用的影响。
JAMA Intern Med. 2016 Sep 1;176(9):1317-23. doi: 10.1001/jamainternmed.2016.3384.
4
Estimation of Potential Savings Through Therapeutic Substitution.通过治疗性替代估计潜在节省。
JAMA Intern Med. 2016 Jun 1;176(6):769-75. doi: 10.1001/jamainternmed.2016.1704.

品牌阿托伐他汀在仿制药阿托伐他汀推出后的使用和支出趋势。

Trends in Use and Expenditures of Brand-name Atorvastatin After Introduction of Generic Atorvastatin.

机构信息

Cardiology Division, Department of Medicine, Duke University Medical Center, Durham, North Carolina.

Center for Healthcare Advancement and Outcomes, Baptist Health South Florida, Miami.

出版信息

JAMA Intern Med. 2018 May 1;178(5):719-721. doi: 10.1001/jamainternmed.2018.0990.

DOI:10.1001/jamainternmed.2018.0990
PMID:29525818
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5885171/
Abstract

This study uses the Medical Expenditure Panel Survey (MEPS) database to analyze trends in use and expenditures of brand-name atorvastin after generic atorvastatin became available.

摘要

本研究使用医疗支出面板调查（MEPS）数据库，分析了在通用阿托伐他汀上市后，品牌阿托伐他汀的使用和支出趋势。